Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Genentech - Wikipedia

    en.wikipedia.org/wiki/Genentech

    Genentech was founded by venture capitalist Robert A. Swanson and biochemist Dr. Herbert W. Boyer. After a meeting in 1976, the two decided to start a biotechnology company, Genentech. Although the two confidently assert that it was the first biotech company, others clearly came before, including Cetus Corporation which was founded in 1971.

  3. Genentech's great deal - AOL

    www.aol.com/news/2009-03-12-genentechs-great...

    Roche will finally buy Genentech (DNA) after months of fighting over a price for the acquisition. According to The Wall Street Journal (subscription required), "Swiss drug maker Roche Holding AG ...

  4. Roche's Genentech buy could kill a technology leader

    www.aol.com/2009/03/12/does-roches-genentech-buy...

    Swiss pharma giant Roche has reached an agreement with Genentech (DNA) to acquire at $95 a share the other 44 percent of the company that Roche doesn't already own. But Genentech -- which had all ...

  5. Aviv Regev - Wikipedia

    en.wikipedia.org/wiki/Aviv_Regev

    Aviv Regev (born 11 July 1971) [3] is a computational biologist and systems biologist and Executive Vice President and Head of Genentech Research and Early Development in Genentech/Roche. [4] She is a core member (on leave) at the Broad Institute of MIT and Harvard and professor (on leave) at the Department of Biology of the Massachusetts ...

  6. Casirivimab/imdevimab - Wikipedia

    en.wikipedia.org/wiki/Casirivimab/imdevimab

    In May 2021, Roche India and Cipla announced that the medicine would be available in India for Rs 59,750 ($808.31) per dose. [ 32 ] In September 2021, the World Health Organization urged producers and governments to address the drug's high cost and called for technology sharing to enable the manufacture of biosimilar versions.

  7. AbbVie-Roche's Venclexta Shows Progression-Free ... - AOL

    www.aol.com/news/abbvie-roches-venclexta-shows...

    Genentech, a unit of Roche Holdings AG (OTC: RHHBY), and its collaborating partner AbbVie Inc (NYSE: ABBV) have announced long-term follow-up data from three Phase 3 trials of Venclexta ...

  8. Astegolimab - Wikipedia

    en.wikipedia.org/wiki/Astegolimab

    It is developed by Genentech/Roche. References This page was last edited on 5 August 2024, at 07:03 (UTC). Text is available under the Creative Commons Attribution ...

  9. Roche buys Roivant's bowel disease drug for $7.1 billion - AOL

    www.aol.com/news/roche-buys-telavant-holdings-7...

    ZURICH/FRANKFURT (Reuters) -Roche on Monday said it will buy Telavant, a developer of a new treatment for inflammatory bowel diseases, for an initial $7.1 billion from U.S biotech firm Roivant ...